LUCAR-G39P cells product
LB2304-0001
Phase 1 mab terminated
Quick answer
LUCAR-G39P cells product for Relapsed and Refractory B-cell Non-Hodgkin Lymphoma is a Phase 1 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated